Trials / Unknown
UnknownNCT04408859
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Quality of Life in Patient With Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Gastric Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 290 (estimated)
- Sponsor
- Peking University Cancer Hospital & Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore the influence of neoadjuvant chemotherapy in the long term quality of life with advanced gastric cancer patients.
Detailed description
Preoperative adjuvant chemotherapy combined with postoperative adjuvant therapy mode was included in the 2018 version of the National Comprehensive Cancer Network (NCCN) guideline as an optional treatment (category 2B) for prospective resectable advanced gastric cancer cases (≥cT2, any N).At home and abroad, the research on neoadjuvant chemotherapy for advanced gastric cancer mainly focuses on the safety and long-term survival, and there are few studies on the quality of life. This study, according to EORTC QLQ-C30 and QLQ-STO22 assessment scale, explores the long term effect of neoadjuvant chemotherapy on the quality of life in patients with advanced gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neoadjuvant Chemotherapy | The patients receive neoadjuvant chemotherapy for 2-4 cycles before surgery. |
Timeline
- Start date
- 2018-04-17
- Primary completion
- 2022-01-10
- Completion
- 2022-01-10
- First posted
- 2020-05-29
- Last updated
- 2020-05-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04408859. Inclusion in this directory is not an endorsement.